<DOC>
	<DOCNO>NCT00349986</DOCNO>
	<brief_summary>The rationale study determine : - first dose titration basal insulin - exact daily time administration basal insulin poorly control type II diabetic patient .</brief_summary>
	<brief_title>LANTUSTITR : Insulin Glargine Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Type 2 Diabetes Mellitus Insufficient combine oral antidiabetic treatment ( biguanide + sulfonylurea ) BMI &gt; 25 kg/m2 , &lt; 30 kg/m2 HbA1c value &gt; 7.0 % , &lt; 9.0 % within one month Type 1 Diabetes Mellitus Known malignancy Drug alcohol abuse Severe liver disease Renal failure ( se Creatinine &gt; 150 micro mol/l ) The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>